Skip to main content
. 2015 Mar 23;17(1):74. doi: 10.1186/s13075-015-0583-8

Figure 2.

Figure 2

Kaplan-Meier curves for time to discontinuation for each group. Drug retention rates were compared using the log-rank test between tocilizumab (TCZ) and tumor necrosis factor inhibitors (TNFIs). The y axis shows the cumulative retention rates.